Jyothy Labs Ltd (JYOTHYLAB) is currently trading at 199.25 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Jyothy Labs Limited manufactures and markets fabric-care, dishwashing, household-insecticide, personal-care and laundry-service products through brands including Ujala, Exo, Maxo and Margo, using 23 Indian manufacturing plants and a broad multi-channel distribution network. Underlying performance was substantially stronger than reported revenue suggests: excluding the discontinued Pril and Fa businesses, second-quarter value growth reached 12.4% and volume growth 8.1%, supported by core brands, selective pricing, new launches and distribution expansion. The principal challenge is severe input-cost inflation. Gross margin fell to 34.8% from 48.1% year-on-year, while operating EBITDA margin declined to 2.5%, as crude-linked materials, chemicals, soap noodles, oils and packaging rose sharply. Liquid detergents are emerging as a strategically important growth engine, expanding over 50% year-on-year despite currently carrying lower economics than powders. Management believes penetration, scale, procurement efficiencies and richer mix can progressively improve category profitability. Jyothy Labs retains substantial financial flexibility despite the earnings pressure, with approximately INR846 crores of cash and no debt. The Board approved a INR147-crore buyback at INR215 per share, while management continues evaluating disciplined acquisitions and new product development.

Over the past 52 weeks, Jyothy Labs Ltd has traded between a low of ₹171.00 and a high of ₹319.05. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Jyothy Labs Ltd has a market capitalization of approximately 7,273.10. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Jyothy Labs Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 19.64 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 7,273.10 Cr, Jyothy Labs Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Jyothy Labs Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Jyothy Labs Ltd is 19.64. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Yes. Jyothy Labs said the Rs 5,000 crore objective remains in place. It did not give a revised date for reaching the target or quantify the contribution expected from launches and acquisitions.

Jyothy Labs said liquids are still scaling and require consumer-conversion investment, giving them different current economics from powders. Management expects penetration, volume scale, procurement efficiency and a richer mix to improve unit economics progressively. It did not disclose a target margin or a date for convergence with powders.

Jyothy Labs reported an operating EBITDA margin of 2.5% in Q2 FY27, compared with 16.1% in Q2 FY26. Operating EBITDA was Rs 19 crore and profit after tax was Rs 10.6 crore for the quarter ended September 30, 2026.

Jyothy Labs said the unprecedented increase in crude prices affected profitability. An analyst said around 65% of the company’s total cost base depends on crude, while management said it is developing lower-dependency products with better margin profiles.